Summit Rock Advisors, LP - Q2 2022 holdings

$122 Million is the total value of Summit Rock Advisors, LP's 8 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 25.0% .

 Value Shares↓ Weighting
XLE SellSELECT SECTOR SPDR TRenergy$60,302,000
-44.8%
843,269
-41.0%
49.27%
-26.3%
IWN BuyISHARES TRrus 2000 val etf$57,183,000
+17.0%
420,000
+38.7%
46.72%
+56.2%
VT  VANGUARD INTL EQUITY INDEX Ftt wrld st etf$2,674,000
-15.7%
31,3290.0%2.18%
+12.6%
WMS NewADVANCED DRAIN SYS INC DEL$671,0007,448
+100.0%
0.55%
DAWN  DAY ONE BIOPHARMACEUTICALS I$593,000
+80.2%
33,1250.0%0.48%
+140.8%
CLOV  CLOVER HEALTH INVESTMENTS CO$451,000
-39.7%
210,6390.0%0.37%
-19.7%
PHAT  PHATHOM PHARMACEUTICALS INC$288,000
-37.9%
34,1000.0%0.24%
-17.3%
DYN  DYNE THERAPEUTICS INC$240,000
-28.6%
34,8870.0%0.20%
-4.9%
MNDY ExitMONDAY COM LTD$0-1,676
-100.0%
-0.16%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-01
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR29Q3 202090.6%
ISHARES TR26Q4 202051.7%
ISHARES INC11Q1 202064.0%
ISHARES TR11Q4 202147.6%
ISHARES TR9Q2 201534.5%
PHATHOM PHARMACEUTICALS INC9Q2 20221.1%
ISHARES TR RUS 2000 VAL ETF7Q4 202247.0%
SELECT SECTOR SPDR TR ENERGY6Q3 202367.4%
VANGUARD INTL EQUITY INDEX F5Q3 202245.3%
VANGUARD INDEX FDS4Q4 202136.4%

View Summit Rock Advisors, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-01-26
13F-HR2023-10-24
13F-HR2023-07-21
13F-HR2023-05-09
13F-HR2023-01-12
13F-HR2022-11-02
13F-HR2022-08-01
13F-HR2022-05-06
13F-HR2022-02-14
13F-HR2021-10-26

View Summit Rock Advisors, LP's complete filings history.

Compare quarters

Export Summit Rock Advisors, LP's holdings